Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,092.16
923.82
1,488.11
1,817.33
1,359.37
707.08
54.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,092.16
923.82
1,488.11
1,817.33
1,359.37
707.08
54.32
Raw Material Cost
243.34
164.78
208.88
179.07
127.69
57.52
24.63
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
185.26
127.77
67.91
24.22
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.51
7.07
1.25
1.26
2.01
14.51
25.00
Selling and Distribution Expenses
494.09
430.96
810.47
970.14
763.81
386.40
46.89
Other Expenses
26.80
30.99
33.03
4.60
-4.55
-3.08
-1.31
Total Expenditure (Excl Depreciation)
1,018.98
912.68
1,350.90
1,381.76
975.80
495.54
107.60
Operating Profit (PBDIT) excl Other Income
73.2
11.100000000000001
137.20000000000002
435.6
383.6
211.5
-53.3
Other Income
74.87
120.15
104.18
42.03
20.08
7.79
9.62
Operating Profit (PBDIT)
218.01
190.09
288.96
512.91
423.22
232.42
-24.31
Interest
13.51
7.07
1.25
1.26
2.01
14.51
25.00
Exceptional Items
228.64
13.40
2.33
6.16
0.00
0.68
0.00
Gross Profit (PBDT)
848.83
759.04
1,279.23
1,638.26
1,231.68
649.55
29.69
Depreciation
80.76
64.58
53.11
41.13
24.75
18.42
22.02
Profit Before Tax
352.39
131.85
236.92
476.68
396.46
200.16
-71.33
Tax
33.80
-7.18
-10.60
31.84
54.63
23.25
-49.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
325.39
139.79
248.99
445.86
343.32
176.94
-22.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
325.39
139.79
248.99
445.86
343.32
176.94
-22.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-9.49
-0.45
0.00
0.00
-1.50
-0.04
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
315.90
139.33
248.99
445.86
341.82
176.91
-22.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,979.04
3,770.59
3,718.07
3,558.50
751.48
408.68
-150.70
Earnings per share (EPS)
0.77
0.33
0.59
1.05
0.81
0.42
-0.05
Diluted Earnings per share
0.77
0.33
0.59
1.05
0.81
0.42
-0.05
Operating Profit Margin (Excl OI)
5.71%
0.58%
8.85%
23.65%
27.84%
29.16%
-103.0%
Gross Profit Margin
39.66%
21.26%
19.49%
28.49%
30.99%
30.91%
-90.78%
PAT Margin
29.79%
15.13%
16.73%
24.53%
25.26%
25.02%
-40.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 18.23% vs -37.92% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 126.78% vs -44.06% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 104.72% vs -62.18% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 90.14% vs 446.15% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Sichuan Huiyu Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,092.16
0
1,092.16
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,092.16
0
1,092.16
Raw Material Cost
243.34
0
243.34
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
13.51
0
13.51
Selling and Distribution Expenses
494.09
0
494.09
Other Expenses
26.80
0.00
26.80
Total Expenditure (Excl Depreciation)
1,018.98
0
1,018.98
Operating Profit (PBDIT) excl Other Income
73.18
0.00
73.18
Other Income
74.87
0
74.87
Operating Profit (PBDIT)
218.01
0
218.01
Interest
13.51
0
13.51
Exceptional Items
228.64
0
228.64
Gross Profit (PBDT)
848.83
0
848.83
Depreciation
80.76
0
80.76
Profit Before Tax
352.39
0
352.39
Tax
33.80
0
33.80
Provisions and contingencies
0
0
0.00
Profit After Tax
325.39
0
325.39
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
325.39
0
325.39
Share in Profit of Associates
0
0
0.00
Minority Interest
-9.49
0
-9.49
Other related items
0.00
0.00
0.00
Consolidated Net Profit
315.90
0
315.90
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,979.04
0
3,979.04
Earnings per share (EPS)
0.77
0
0.77
Diluted Earnings per share
0.77
0
0.77
Operating Profit Margin (Excl OI)
5.71%
0%
0.00
5.71%
Gross Profit Margin
39.66%
0%
0.00
39.66%
PAT Margin
29.79%
0%
0.00
29.79%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 109.22 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 18.23% vs -37.92% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 31.59 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 126.78% vs -44.06% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.31 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 104.72% vs -62.18% in Dec 2023
Annual - Interest
Interest 1.35 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 90.14% vs 446.15% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.71%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






